These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2910410)

  • 1. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.
    Hayashi Y; Kanda N; Inaba T; Hanada R; Nagahara N; Muchi H; Yamamoto K
    Cancer; 1989 Jan; 63(1):126-32. PubMed ID: 2910410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants.
    Hayashi Y; Inaba T; Hanada R; Yamada M; Nakagome Y; Yamamoto K
    Med Pediatr Oncol; 1989; 17(2):111-5. PubMed ID: 2704332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different karyotypic patterns in early and advanced stage neuroblastomas.
    Kaneko Y; Kanda N; Maseki N; Sakurai M; Tsuchida Y; Takeda T; Okabe I; Sakurai M
    Cancer Res; 1987 Jan; 47(1):311-8. PubMed ID: 3791218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma. Effect of genetic factors on prognosis and treatment.
    Brodeur GM; Azar C; Brother M; Hiemstra J; Kaufman B; Marshall H; Moley J; Nakagawara A; Saylors R; Scavarda N
    Cancer; 1992 Sep; 70(6 Suppl):1685-94. PubMed ID: 1325279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of clinical heterogeneity in neuroblastoma.
    Brodeur GM; Nakagawara A
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):111-6. PubMed ID: 1356315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neuroblastomas.
    Tomioka N; Kobayashi H; Kageyama H; Ohira M; Nakamura Y; Sasaki F; Todo S; Nakagawara A; Kaneko Y
    Genes Chromosomes Cancer; 2003 Feb; 36(2):139-50. PubMed ID: 12508242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of neuroblastomas in Japan found by screening.
    Hayashi Y; Hanada R; Yamamoto K
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):342-7. PubMed ID: 1456401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
    Look AT; Hayes FA; Shuster JJ; Douglass EC; Castleberry RP; Bowman LC; Smith EI; Brodeur GM
    J Clin Oncol; 1991 Apr; 9(4):581-91. PubMed ID: 2066755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor cytogenetics and prognosis in neuroblastoma].
    Christiansen H; Lampert F
    Monatsschr Kinderheilkd; 1989 Oct; 137(10):666-71. PubMed ID: 2586532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.
    Kaneko Y; Kanda N; Maseki N; Nakachi K; Takeda T; Okabe I; Sakurai M
    J Clin Oncol; 1990 Dec; 8(12):2005-13. PubMed ID: 2230892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma.
    Christiansen H; Lampert F
    Br J Cancer; 1988 Jan; 57(1):121-6. PubMed ID: 3348945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma--clinical applications of molecular parameters.
    Brodeur GM
    Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma: clinical significance of genetic abnormalities.
    Brodeur GM
    Cancer Surv; 1990; 9(4):673-88. PubMed ID: 2101728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
    Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems of mass screening for neuroblastoma: analysis of false-negative cases.
    Ishimoto K; Kiyokawa N; Fujita H; Yabuta K; Ohya T; Miyano T; Shinohara T; Sera Y
    J Pediatr Surg; 1990 Apr; 25(4):398-401. PubMed ID: 2329455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
    Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
    N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening.
    Hayashi Y; Inaba T; Hanada R; Yamamoto K
    J Pediatr; 1988 Apr; 112(4):567-71. PubMed ID: 3351679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of near-diploid DNA content and N-myc amplification in neuroblastomas.
    Dominici C; Negroni A; Romeo A; Castello MA; Clerico A; Scopinaro M; Mauro F; Raschellà G
    Clin Exp Metastasis; 1989; 7(2):201-11. PubMed ID: 2920475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neuroblastomas and abnormalities of chromosomes 1 and 17.
    Gilbert F; Feder M; Balaban G; Brangman D; Lurie DK; Podolsky R; Rinaldt V; Vinikoor N; Weisband J
    Cancer Res; 1984 Nov; 44(11):5444-9. PubMed ID: 6488196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.